期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血浆溶血磷脂酸水平测定在缺血性脑血管病防治中的意义 被引量：1

在线阅读 下载PDF
导出
摘要 目的探讨缺血性脑血管病患者血浆溶血磷脂酸(LPA)水平变化。方法对361例急性缺血性脑血管病(包括短暂性脑缺血发作及脑梗死)患者及236例体检者进行血浆溶血磷脂酸水平测定并对体检有LPA增高者进行随访3～6月。结果短暂性脑缺血发作(TIA)及脑梗死者入院时LPA水平均明显高于健康对照者(2.04±0.7)μmol/L(正常值<2.9μmol/L)分别为(4.12±0.65)μmol/L、(3.74±0.56)μmol/L(P<0.05),经抗血小板治疗后LPA分别平均下降至(2.06±0.91)μmol/L及(2.45±0.62)μmol/L;体检者中有LPA增高者共49例(3.54±0.36)μmol/L,随访3～6月共有3例发生脑梗死,8例发生短暂性脑缺血发作。结论 LPA可以作为脑缺血性疾病发作的预警信号,为诊断治疗及判断预后提供帮助。
作者 石兴超
机构地区 南阳市第三人民医院
出处 《中国医学创新》 CAS 2008年第30期41-42,共2页 Medical Innovation of China
关键词 缺血性脑血管病 血浆溶血磷脂酸
分类号 R743.31 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献5

  • 1江波,江林涌,周汉良.磷脂酸和溶血磷脂酸的生理功能[J].生理科学进展,2002,33(2):159-162. 被引量：18
  • 2孙玉衡,伍期专,姚存姗,黄世昌,唐朝枢,李振光,包鹤丘,李松,周伟仅.缺血性脑卒中患者血浆溶血磷脂酸水平的初步研究[J].中华医学杂志,2002,82(4):229-231. 被引量：107
  • 3Moolenaar WH.Lysophosphatidic acid, a multifunctional phospholipids messenger[].Journal of Biological Chemistry.1995
  • 4Gerrard JM,Robinson P,Narvey M,et al.Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation[].Biochemistry and Cell Biology.1993
  • 5Pasquet JM,Gross BS,Gratacap MP,et al.Thrombopoietin potentiates collagen receptor signalling in platelets through a pHos-pHatidylinositol 3- kinase- dependent pathway[].Blood.2000

二级参考文献16

  • 1Moolenaar WH. Lysophosphatidic acid,a multifunctional phospholipid messenger. J Biol Chem,1995, 270: 12949-12952.
  • 2Tokumura A, Iimori M, Nishioka Y, et al. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol,1994, 267: C204-210.
  • 3Jalink K, Hordijk PL, Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim Biophys Acta,1994, 1198: 185-196.
  • 4Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers JAMA, 1998,280: 719-723.
  • 5Eichholtz T,Jalink K,Fahrenfort I,et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J,1993, 291 : 677-680.
  • 6Torti M, Tolnai Festetics E, Bertoni A, et al. Activation of human platelets by lysophosphatidic acid. Blood Coagul Fibrinolysis,1996,7: 253-255.
  • 7Zhang J, Rittenhouse SE. Lysophosphatidic acid activates phosphoinositide 3-kinase and phospholipase C in human platelets: inhibitory effects of wortmannin on phosphoinositide 3-kinase and aggregation. Biochem Biophys Res Commun,1995, 211: 484-490.
  • 8Gueguen G, Gaige B, Grevy JM,et al. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation. Biochemistry,1999,38: 8440-8450.
  • 9Gerrard JM, Robinson P.Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim Biophys Acta, 1989, 1001: 282-285
  • 10Gerrard JM,Robinson P,Narvey M,et al. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation,Biochem Cell Biol,1993, 71: 432-439.

共引文献123

同被引文献31

引证文献1

二级引证文献4

中国医学创新
2008年 第30期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部